Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cellectricon, a life sciences solutions provider of advanced screening products and services to accelerate drug discovery and cell-based assay research, has named David Burns as the CEO.
Subscribe to our email newsletter
Burns has held executive management positions at Renishaw Diagnostics, Cyntellect, GE Healthcare, Imaging Research, BioSignal Packard, and Pharmacia / LKB.
Cellectricon chairman Axel Broms said they are looking forward to working with him in formulating and broadening the product offering using the company’s strong IP and technology position.
"David’s experience in both research instruments and service businesses complements Cellectricon’s strategic aim to deliver more value to its customers by offering assay development services based on Cellectricons in-house technology expertise in addition to instrument sales," Broms said.